The effect of perioperative intra-articular magnesium on postoperative pain after shoulder surgery
Phase 4
Completed
- Conditions
- ASA 1-2 patients scheduled for arthroscopic shoulder surgery by the Orthopaedics Department.Anaesthesiology - Pain management
- Registration Number
- ACTRN12613001360707
- Lead Sponsor
- Meram Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
The inclusion criteria were participants are scheduled for arthroscopic shoulder surgery who not to have had any analgesic or corticosteroid for preceeding 72 hours, not to have any drug or alcohol addiction, not to be allergic to study drugs, and be able to use patient controlled analgesia
Exclusion Criteria
Exclusion criteria included; known allergy to one of the study drugs; major hepatic, renal, or cardiovascular dysfunction, especially atrioventricular block; and prior treatment with opioids and calcium channel blockers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative pain reduction. Pain assessment done with visual analogue scale.[At postoperative 24 hours.]; If any decrement present in total diclofenac consumption (It is allowed 2 times diclofenac injection if patient wants) and intraarticular morphine + bupivacaine consumption (with patient controlled analgesia device) in magnesium group when compared to control group.<br><br>Diclofenac amount recorded at study protocol paper. Morphine bupivacaine amount recorded study protocol paper by looking at the PCA device. [At the end of postoperative 24 hours]
- Secondary Outcome Measures
Name Time Method Shoulder pain assessment with visuel analogue scale.[At 1,2,6,8,12,18,24 hours after the operation. ]